Peter Seideman

1.5k total citations
49 papers, 1.1k citations indexed

About

Peter Seideman is a scholar working on Rheumatology, Pharmacology and Pharmacology. According to data from OpenAlex, Peter Seideman has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 12 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in Peter Seideman's work include Rheumatoid Arthritis Research and Therapies (12 papers), Inflammatory mediators and NSAID effects (11 papers) and Analytical Methods in Pharmaceuticals (8 papers). Peter Seideman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Inflammatory mediators and NSAID effects (11 papers) and Analytical Methods in Pharmaceuticals (8 papers). Peter Seideman collaborates with scholars based in Sweden, United Kingdom and Australia. Peter Seideman's co-authors include Olof Beck, Staffan Eksborg, R Müller-Suur, Christer von Bahr, Gunnar Alván, Berit Calissendorff, K. Haglund, Curt Peterson, Gunnar Widmark and Björn Lindström and has published in prestigious journals such as IEEE Transactions on Pattern Analysis and Machine Intelligence, Annals of the Rheumatic Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

Peter Seideman

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Seideman Sweden 21 311 211 179 164 119 49 1.1k
B McConkey United Kingdom 24 925 3.0× 69 0.3× 263 1.5× 242 1.5× 190 1.6× 56 1.9k
Jarle Aarbakke Norway 25 199 0.6× 825 3.9× 120 0.7× 173 1.1× 602 5.1× 111 2.0k
Israeli A. Jaffe United States 20 304 1.0× 40 0.2× 112 0.6× 59 0.4× 244 2.1× 36 1.2k
Demetrios Vlahakos Greece 26 230 0.7× 37 0.2× 68 0.4× 318 1.9× 392 3.3× 71 1.8k
Nada Majkić‐Singh Serbia 16 87 0.3× 80 0.4× 45 0.3× 119 0.7× 185 1.6× 130 1.0k
Ying Zhou China 22 71 0.2× 59 0.3× 128 0.7× 81 0.5× 322 2.7× 103 1.4k
M. E. Pickup United Kingdom 15 178 0.6× 27 0.1× 131 0.7× 42 0.3× 68 0.6× 32 695
Jonathan A. Leff United States 24 406 1.3× 103 0.5× 64 0.4× 135 0.8× 268 2.3× 45 2.5k
Junko Abe Japan 26 54 0.2× 67 0.3× 177 1.0× 57 0.3× 478 4.0× 81 1.9k
H. Verhaegen Belgium 22 57 0.2× 48 0.2× 107 0.6× 47 0.3× 266 2.2× 85 1.5k

Countries citing papers authored by Peter Seideman

Since Specialization
Citations

This map shows the geographic impact of Peter Seideman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Seideman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Seideman more than expected).

Fields of papers citing papers by Peter Seideman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Seideman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Seideman. The network helps show where Peter Seideman may publish in the future.

Co-authorship network of co-authors of Peter Seideman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Seideman. A scholar is included among the top collaborators of Peter Seideman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Seideman. Peter Seideman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seideman, Peter, et al.. (2004). Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets.. PubMed. 31(12). 2347–55. 63 indexed citations
2.
Pettersson, Birgitta, et al.. (1995). Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 665(1). 163–170. 37 indexed citations
3.
Albertioni, Freidoun, Olof Beck, C. Peterson, et al.. (1995). Methotrexate in juvenile rheumatoid arthritis. European Journal of Clinical Pharmacology. 47(6). 507–11. 41 indexed citations
4.
Seideman, Peter, et al.. (1994). The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.. British Journal of Clinical Pharmacology. 38(3). 221–227. 16 indexed citations
5.
Seideman, Peter, Freidoun Albertioni, Olof Beck, Staffan Eksborg, & Curt Peterson. (1994). Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 37(6). 830–833. 36 indexed citations
6.
Seideman, Peter, et al.. (1993). Renal effects of low dose methotrexate in rheumatoid arthritis.. PubMed. 20(7). 1126–8. 42 indexed citations
7.
Walker, Judith S., Romualda D. Knihinicki, Peter Seideman, & Richard O. Day. (1993). Pharmacokinetics Of Ibuprofen Enantiomers In Plasma And Suction Blister Fluid In Healthy Volunteers. Journal of Pharmaceutical Sciences. 82(8). 787–790. 9 indexed citations
8.
Johnson, Anthony G., Peter Seideman, & Richard O. Day. (1993). Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Drug Safety. 8(2). 99–127. 34 indexed citations
9.
Seideman, Peter & R Müller-Suur. (1993). Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis.. Annals of the Rheumatic Diseases. 52(8). 613–615. 28 indexed citations
10.
Seideman, Peter. (1993). Better effect of methotrexate on C-reactive protein during daily compared to weekly treatment in rheumatoid arthritis. Clinical Rheumatology. 12(2). 210–213. 4 indexed citations
11.
Seideman, Peter. (1993). Paracetamol in rheumatoid arthritis.. PubMed. 44. 7–12. 6 indexed citations
12.
Beck, Olof, et al.. (1991). Trace Analysis of Methotrexate and 7-Hydroxymethotrexate in Human Plasma and Urine by a Novel High-Performance Liquid Chromatographic Method. Therapeutic Drug Monitoring. 13(6). 528–532. 39 indexed citations
13.
Seideman, Peter & Magnus von Arbin. (1991). Cerebral blood flow and indomethacin drug levels in subjects with and without central nervous side effects.. British Journal of Clinical Pharmacology. 31(4). 429–432. 27 indexed citations
14.
Seideman, Peter, et al.. (1990). An interobject distance measure based on medial axes retrieved from discrete distance maps. IEEE Transactions on Pattern Analysis and Machine Intelligence. 12(4). 390–397. 4 indexed citations
15.
Allander, Erik, et al.. (1989). Computerized Assessment of Radiological Changes of the Hand in Rheumatic Diseases. Scandinavian Journal of Rheumatology. 18(5). 291–296. 15 indexed citations
16.
Seideman, Peter, et al.. (1989). Debrisoquine Hydroxylation Phenotype in SLE Patients. Scandinavian Journal of Rheumatology. 18(1). 63–64. 2 indexed citations
17.
Wahlin‐Boll, E, et al.. (1989). Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin. European Journal of Clinical Pharmacology. 37(1). 7–15. 6 indexed citations
18.
Seideman, Peter & A. Melander. (1988). EQUIANALGESIC EFFECTS OF PARACETAMOL AND INDOMETHACIN IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 27(2). 117–122. 33 indexed citations
19.
Seideman, Peter, A. Grahnén, K. Haglund, B. Lindström, & Christer von Bahr. (1982). Prazosin first dose phenomenon during combined treatment with a beta‐ adrenoceptor blocker in hypertensive patients.. British Journal of Clinical Pharmacology. 13(6). 865–870. 14 indexed citations
20.
Seideman, Peter, et al.. (1981). Effect of Pentobarbital on the Formation of Diastereomeric Oxazepam Glucuronides in Man: Analysis by High Performance Liquid Chromatography. Acta Pharmacologica et Toxicologica. 49(3). 200–204. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B McConkey Breakdown of academic impact, for papers by Jarle Aarbakke Breakdown of academic impact, for papers by Israeli A. Jaffe Breakdown of academic impact, for papers by Demetrios Vlahakos Breakdown of academic impact, for papers by Nada Majkić‐Singh Breakdown of academic impact, for papers by Ying Zhou Breakdown of academic impact, for papers by M. E. Pickup Breakdown of academic impact, for papers by Jonathan A. Leff Breakdown of academic impact, for papers by Junko Abe Breakdown of academic impact, for papers by H. Verhaegen
Rankless by CCL
2026